Skip to main content

MedWell Ai Reports Strong Q2 Revenues Of $548,315 And Provides Guidance For Full Year 2025 Exceeding $2,200,000

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

CLEARWATER, Fla., Feb. 23, 2026 (GLOBE NEWSWIRE) — via IBN — MedWell Ai, Inc, (OTCQB:MWAI) (“Company”) is a portfolio company, specializing in AI-driven solutions for B2B markets in pharmaceuticals, healthcare, and wellness, is pleased to confirm the filing, after the market close, of its Quarterly Report (Form 10-Q), for the financial period, ending on December 31, 2025.

The Company reported $548,315 in Revenue for its fiscal second quarter of 2025. This performance was result of a successful strategic shift toward building an AI-driven healthcare, pharmaceutical and biological wellness portfolio. 

Key Financial Highlights:

Increased Total Revenues:

  • For three months, ended December 31, 2025, Company had generated total revenues of 548,315 vs $142,861 for three months, ended December 31, 2024 (280%+ increase).
  • For six months, ended December 31, 2025, Company had generated total revenues of $1,075,806 vs $144,009 for six months, ended December, 2024 (700%+ increase).

Reduced Total Loss From Operations:

  • For three months, ended December 31, 2025, Company’s net loss was reduced to $266,221 vs $315,096 for three months, ended December 31, 2024.
  • For six months, ended December 31, 2025, Company’s net loss was reduced to $592,255 vs $904,080 for six months, ended December 31, 2024.

Reduced General And Administrative Expenses:

  • For three months, ended December 31, 2025, Company’s expenses were reduced to $388,509 vs $625,199 for three months, ended December 31, 2024.
  • For six months, ended December 31, 2025, Company’s expenses were reduced to $796,839 vs $960,413 for six months, ended December 31, 2024.

Reduced Net Loss Per Common Share:

  • For three months, ended December 31, 2025, Company’s net loss was reduced to 0.045 cents vs 0.062 cents for three months, ended December 31, 2024.
  • For six months, ended December 31, 2025, Company’s net loss was reduced to 0.138 cents vs 0.174 cents for six months, ended December 31, 2024. 

Total Liabilities/Mezzanine/Stockholder’s Deficit:  For three months, ended December 31, 2025, Company’s liabilities deficit was reduced to $468,655 from $805,500, for three months, ended June 30, 2025.

Steve Rubakh, CEO of MedWell Ai, Inc, comments:

“MWAI is a newly formed entity (formerly Integrated Ventures, Inc) is operating in AI-driven pharma/healthcare/wellness category. Q2 financial results reflect significant top-line progress for fast growing small cap company, driven by its B2B pharma procurement arm, MedWell USA, which focuses on high-demand in-office use, wellness products, like compounded GLP-1 agonists for weight management.

The current revenue ramp up suggests a successful scaling process in the competitive but rapidly growing regenerative wellness and telemedicine space. This aligns with recent trends in longevity, personalized medicine and corporate wellness markets.

Please visit our corporate websites for additional information: ( 1) Corporate:  www.medwellai.com, (2) Pharma Procurement/E-Portal: www.medwellusa.com and (3) 24/7 Telemedicine: www.telemd.ai launching soon).”

Safe Harbor Statement:

The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words “may,” “will,” “should,” “plans,” “explores,” “expects,” “anticipates,” “continue,” “estimate,” “project,” “intend,” and similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, and various other factors beyond the company’s control.

 InvestorWire Service Contact:

IBN
Austin, Texas
www.InvestorBrandNetwork.com
512.354.7000 Office
Editor@InvestorBrandNetwork.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.